Informations générales (source: ClinicalTrials.gov)
a French Observational Prospective Multicenter Study of Adult Patients Treated in the Real-life Setting With Olaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer (PROWESs)
Observational
AstraZeneca (Voir sur ClinicalTrials)
octobre 2023
octobre 2028
24 septembre 2024
This French non-interventional prospective multicenter cohort study is conducted to study
the added value of olaparib in the treatment of patients with mCRPC in the real world
setting in terms of treatment sequencing, effectiveness, safety and BRCA testing patterns
and thus inform future clinical practice.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL NOVO | ASSOUAD | 04/07/2024 11:05:05 | Contacter | ||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| HIA BEGIN | Contact (sur clinicalTrials) | ||||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Research Site - Amiens - France | Contact (sur clinicalTrials) | ||||
| Research Site - Angers Cedex 9 - France | Contact (sur clinicalTrials) | ||||
| Research Site - Antony - France | Contact (sur clinicalTrials) | ||||
| Research Site - Argenteuil - France | Contact (sur clinicalTrials) | ||||
| Research Site - Avignon - France | Contact (sur clinicalTrials) | ||||
| Research Site - Besancon - France | Contact (sur clinicalTrials) | ||||
| Research Site - Bordeaux - France | Contact (sur clinicalTrials) | ||||
| Research Site - Challes Les Eaux - France | Contact (sur clinicalTrials) | ||||
| Research Site - Chambray Les Tours - France | Contact (sur clinicalTrials) | ||||
| Research Site - Champigny Sur Marne - France | Contact (sur clinicalTrials) | ||||
| Research Site - Clermont-ferrand Cedex 1 - France | Contact (sur clinicalTrials) | ||||
| Research Site - Compiegne Cedex - France | Contact (sur clinicalTrials) | ||||
| Research Site - Creteil - France | Contact (sur clinicalTrials) | ||||
| Research Site - Epagny METZ Tessy - France | Contact (sur clinicalTrials) | ||||
| Research Site - FORT DE France - France | Contact (sur clinicalTrials) | ||||
| Research Site - Frejus Cedex - France | Contact (sur clinicalTrials) | ||||
| Research Site - Grenoble Cedex 9 - France | Contact (sur clinicalTrials) | ||||
| Research Site - Le Chesnay - France | Contact (sur clinicalTrials) | ||||
| Research Site - Le Coudray - France | Contact (sur clinicalTrials) | ||||
| Research Site - Le Mans - France | Contact (sur clinicalTrials) | ||||
| Research Site - Levallois Perret - France | Contact (sur clinicalTrials) | ||||
| Research Site - Lyon - France | Contact (sur clinicalTrials) | ||||
| Research Site - Lyon Cedex 09 - France | Contact (sur clinicalTrials) | ||||
| Research Site - Mantes La Jolie - France | Contact (sur clinicalTrials) | ||||
| Research Site - Marseille - France | Contact (sur clinicalTrials) | ||||
| Research Site - Morlaix - France | Contact (sur clinicalTrials) | ||||
| Research Site - Nancy - France | Contact (sur clinicalTrials) | ||||
| Research Site - Nantes - France | Contact (sur clinicalTrials) | ||||
| Research Site - Nice Cedex 2 - France | Contact (sur clinicalTrials) | ||||
| Research Site - Orléans - France | Contact (sur clinicalTrials) | ||||
| Research Site - Paris - France | Contact (sur clinicalTrials) | ||||
| Research Site - Pointe A Pitre - France | Contact (sur clinicalTrials) | ||||
| Research Site - Poitiers - France | Contact (sur clinicalTrials) | ||||
| Research Site - Pontoise - France | Contact (sur clinicalTrials) | ||||
| Research Site - Quint Fonsegrives - France | Contact (sur clinicalTrials) | ||||
| Research Site - Rouen - France | Contact (sur clinicalTrials) | ||||
| Research Site - Saint Denis- LA Reunion - France | Contact (sur clinicalTrials) | ||||
| Research Site - Saint Doulchard - France | Contact (sur clinicalTrials) | ||||
| Research Site - Saint-etienne - France | Contact (sur clinicalTrials) | ||||
| Research Site - Saint-etienne Cedex 1 - France | Contact (sur clinicalTrials) | ||||
| Research Site - Saint-gregoire - France | Contact (sur clinicalTrials) | ||||
| Research Site - St Nazaire - France | Contact (sur clinicalTrials) | ||||
| Research Site - Strasbourg - France | Contact (sur clinicalTrials) | ||||
| Research Site - Tours - France | Contact (sur clinicalTrials) | ||||
| Research Site - Vannes - France | Contact (sur clinicalTrials) | ||||
| Research Site - Vantoux - France | Contact (sur clinicalTrials) | ||||
Critères
Homme
Inclusion Criteria:
- Adult male patients (≥ 18 years old)
- With metastatic castration-resistant prostate cancer - Who have initiated olaparib
within the last two months of study entry, or for whom the decision to be treated
with olaparib has been made by their physician
- Who have been informed and are not opposed to this data collection
- Adult male patients (≥ 18 years old)
- With metastatic castration-resistant prostate cancer - Who have initiated olaparib
within the last two months of study entry, or for whom the decision to be treated
with olaparib has been made by their physician
- Who have been informed and are not opposed to this data collection
- Patients opposed to the collection of their data
- Patients participating in a clinical trial with an investigational prostate cancer
targeted drug within 30 days prior to Olaparib initiation